MTF Biologics:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MTF Biologics - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6568
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MTF Biologics(MTF) formerly known as Musculoskeletal Transplant Foundation, is a subsidiary of Donor Network West is a medical foundation that offers clinically sound and safe allograft tissue. The foundation offers allograft bone, sports tissue and dermal tissues. Its products include morselized allografts, spine and general orthopaedic tissue, spinal spacers, large segmental and reconstructive tissue, ligament reconstruction, meniscus and cartilage, biologics, scaffolds and fixation, acellular dermal allografts and cypropreserved split thickness skin grafts. MTF’s donor services division provides customized, need-based services to organ, tissue and eye recovery agencies through donor related education and support. The company has its presence in Pennsylvania, California and Germany MTF is headquartered in Edison, New Jersey, the US.

MTF Biologics – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MTF Biologics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MTF Biologics, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MTF Biologics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MTF Biologics, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
MTF Biologics, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MTF Biologics, Medical Equipment, Deal Details 11
Asset Purchase 11
Musculoskeletal Transplant Acquires Orthopedic Business From Cascade Medical Enterprises 11
Venture Financing 12
Bone Biologics Raises USD5.75 Million in Venture Financing 12
Partnerships 13
BoneSupport Receives Rights from MTF Biologics 13
Orthofix International Enters Into Co-Development Agreement With Musculoskeletal Transplant 14
Orthofix International Expands Co-Development Agreement With Musculoskeletal Transplant 15
Equity Offering 16
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of Shares 16
MTF Biologics – Key Competitors 18
MTF Biologics – Key Employees 19
MTF Biologics – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
Mar 02, 2017: MTF Announces New Recovery Partner Relationship — LifeLink 21
Mar 02, 2017: MTF Announces New Recovery Partner Relationship — New England Donor Services 22
Corporate Communications 23
Apr 10, 2018: MTF Biologics Appoints Joe Yaccarino President And CEO 23
Sep 21, 2017: Bruce Stroever to Retire from Musculoskeletal Transplant Foundation 24
Jun 13, 2017: MTF Announces Matthew Kuehnert, MD as New Medical Director 25
Feb 01, 2017: MTF appoints Joseph Roth to Board of Directors 26
Legal and Regulatory 27
Oct 02, 2017: Court Sets the Trial Date for MiMedx Patent Infringement Lawsuit Against MTF, Medline and Liventa 27
Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates 28
Government and Public Interest 29
Sep 25, 2018: The Plastic Surgery Foundation and MTF Biologics Open Applications for Allograft Tissue Research Grant Program 29
Product News 30
Mar 07, 2018: MTF Biologics and the University of Missouri Highlight Positive Clinical Results for Missouri Osteochondral Allograft Preservation System 30
Oct 03, 2017: World’s Largest Tissue Bank Rebrands to MTF Biologics 31
Other Significant Developments 32
Feb 06, 2018: MTF Biologics Distributes More Than 550,000 Tissue Grafts in 2017, Saving and Healing a Record Number of Lives 32
Oct 30, 2017: Plastic Surgery Foundation and MTF Biologics Partnership Funds Advances in Tissue Transplantation 33
Sep 28, 2017: DSM partners with the Musculoskeletal Transplant Foundation for distribution of regenerative materials and products 34
Jul 11, 2017: MTF Awards $1.74 Million in 2017 Extramural Research Grants 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
MTF Biologics, Medical Equipment, Key Facts 2
MTF Biologics, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MTF Biologics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MTF Biologics, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MTF Biologics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MTF Biologics, Deals By Market, 2012 to YTD 2018 9
MTF Biologics, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Musculoskeletal Transplant Acquires Orthopedic Business From Cascade Medical Enterprises 11
Bone Biologics Raises USD5.75 Million in Venture Financing 12
BoneSupport Receives Rights from MTF Biologics 13
Orthofix International Enters Into Co-Development Agreement With Musculoskeletal Transplant 14
Orthofix International Expands Co-Development Agreement With Musculoskeletal Transplant 15
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of Shares 16
MTF Biologics, Key Competitors 18
MTF Biologics, Key Employees 19
MTF Biologics, Other Locations 20

List of Figures
MTF Biologics, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MTF Biologics, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MTF Biologics, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MTF Biologics, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MTF Biologics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MTF Biologics, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
MTF Biologics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MTF Biologics, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[MTF Biologics:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Louisiana-Pacific Corporation:戦略・SWOT・企業財務分析
    Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report Summary Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • NEC Corp (6701):企業の財務・戦略的SWOT分析
    NEC Corp (6701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • A. Schulman Inc (SHLM):企業の財務・戦略的SWOT分析
    A. Schulman Inc (SHLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Hibbett Sports Inc:戦略・SWOT・企業財務分析
    Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report Summary Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Natural Resource Partners L.P.:企業のM&A・事業提携・投資動向
    Natural Resource Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Natural Resource Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Vedanta Ltd:戦略・SWOT・企業財務分析
    Vedanta Ltd - Strategy, SWOT and Corporate Finance Report Summary Vedanta Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Northland Power Inc (NPI)-エネルギー分野:企業M&A・提携分析
    Summary Northland Power Inc. (Northland Power) is an independent power producer. It develops, finances, builds, owns, and operates clean and green power projects in Canada and internationally. The company generates energy from natural gas, biomass, landfill gas, wind and solar sources. In thermal ge …
  • Maverick Natural Resources LLC:企業の戦略的SWOT分析
    Maverick Natural Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Great Western Bancorp Inc.:企業の戦略・SWOT・財務情報
    Great Western Bancorp Inc. - Strategy, SWOT and Corporate Finance Report Summary Great Western Bancorp Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SAS Group:戦略・SWOT・企業財務分析
    SAS Group - Strategy, SWOT and Corporate Finance Report Summary SAS Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Enmax Corp:企業の発電所・SWOT分析2018
    Enmax Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Univision Communications Inc.:企業の戦略・SWOT・財務分析
    Univision Communications Inc. - Strategy, SWOT and Corporate Finance Report Summary Univision Communications Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Glenmark Pharmaceuticals Ltd (GLENMARK):企業の財務・戦略的SWOT分析
    Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Centrotec Sustainable AG (CEV):企業の財務・戦略的SWOT分析
    Summary Centrotec Sustainable AG (Centrotec) is an energy company that provides energy saving systems. The company provides products such as medical technology plastics, climate systems, gas flue systems and engineering plastics, among others. It also offers ventilation with heat recovery, heating s …
  • General Re Corporation:企業の戦略・SWOT・財務情報
    General Re Corporation - Strategy, SWOT and Corporate Finance Report Summary General Re Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cosmax Inc.:企業の戦略・SWOT・財務情報
    Cosmax Inc. - Strategy, SWOT and Corporate Finance Report Summary Cosmax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ABX Advanced Biochemical Compounds GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a provider of biochemical compounds that manufactures, develops, and distributes biochemicals for nuclear medicine. The company provides products such as PET and SPECT precursors and reference standards, …
  • Cidara Therapeutics Inc (CDTX):企業の財務・戦略的SWOT分析
    Summary Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include novel echinocandin CD101 IV, for the treatment of systemic candida in …
  • Genocea Biosciences Inc (GNCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Genocea Biosciences Inc (Genocea), formerly GenoceaInc, is a cancer vaccines provider. The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. It provides Gen-009 and Gen-010 neoantigen cancer Vaccine pipeline.Genoceaatlas tech …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆